Acute, sequence-specific effects of oxytocin and vasopressin antisense oligonucleotides on neuronal responses.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuroscience

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0306-4522(95)00394-XPMID 8848114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasopressin facilitates its own release within the rat supraoptic nucleus in vivo.

  1994cited by this paper
• An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats.

  1994cited by this paper
• Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain.

  1994cited by this paper
• Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus.

  1994cited by this paper
• Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.

  1994cited by this paper
• Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

  1993cited by this paper
• Novel approaches to the study of oxytocin neurotransmission in the rat brain.

  1993cited by this paper
• Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat.

  1993cited by this paper
• Arginine Vasopressin Levels after Daily Infusions of Antisense Oligonucleotides into the Supraoptic Nucleus a

  1993cited by this paper
• Antisense Effect of Oligodeoxynucleotides with Inverted Terminal Internucleotidic Linkages: A Minimal Modification Protecting against Nucleolytic Degradation

  1992cited by this paper
• Cholecystokinin Activates C‐Fos Expression in Hypothalamic Oxytocin and Corticotropin‐Releasing Hormone Neurons

  1991cited by this paper
• Electrical activation and c‐fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin.

  1991cited by this paper
• Electrophysiology of mammalian magnocellular vasopressin and oxytocin neurosecretory neurons

  1990cited by this paper
• Characterization of oligonucleotide transport into living cells.

  1989cited by this paper
• Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

  1989cited by this paper
• Cholecystokinin and gastric distension activate oxytocinergic cells in rat hypothalamus.

  1987cited by this paper
• Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety.

  1986cited by this paper
• Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay.

  1981cited by this paper

• The Impact of Inflammation on Thermal Hyperpnea: Relevance for Heat Stress and Febrile Seizures

  2024cites this paper
• The translational inhibitor and amnestic agent emetine also suppresses ongoing hippocampal neural activity similarly to other blockers of protein synthesis

  2024cites this paper
• Tracking oxytocin functions in the rodent brain during the last 30 years: From push‐pull perfusion to chemogenetic silencing

  2019cites this paper
• Mediation of memory permanence: Neural activity versus protein synthesis

  2017cites this paper
• Alterations to the Membrane Properties of CA1 Pyramidal Neurons by the Amnestic Agent Anisomycin

  2017cites this paper
• ZIP It: Neural Silencing Is an Additional Effect of the PKM-Zeta Inhibitor Zeta-Inhibitory Peptide

  2016cites this paper
• ANI inactivation: Unconditioned anxiolytic effects of anisomycin in the ventral hippocampus

  2014cites this paper
• Neurosilence: Profound Suppression of Neural Activity following Intracerebral Administration of the Protein Synthesis Inhibitor Anisomycin

  2012cites this paper
• Neurosilence: intracerebral applications of protein synthesis inhibitors eliminate neural activity

  2010cites this paper
• Long‐term suppression of methamphetamine‐induced c‐Fos expression in rat striatum by the injection of c‐fos antisense oligodeoxynucleotides absorbed in water‐absorbent polymer

  2004cites this paper
• In Vivo Gene Transfer Studies on the Regulation and Function of the Vasopressin and Oxytocin Genes

  2003cites this paper
• Effect of AVT antisense oligodeoxynucleotides on AVT release induced by hypertonic stimulation in chicks.

  2001cites this paper
• cAMP Stimulation of Vasopressin and Oxytocin Release and Regulation of Vasopressin mRNA Stability: Role of Auto‐Facilitation

  2001cites this paper
• Transgenic Rats and the Functional Genomics of Endocrine Systems

  2001cites this paper
• cAMP stimulation of vasopressin and oxytocin release and regulation of vasopressin mRNA stability: role of auto-facilitation.

  2001cites this paper
• Gene regulation in the magnocellular hypothalamo-neurohypophysial system.

  2001cites this paper
• Prolactin: structure, function, and regulation of secretion.

  2000cites this paper
• Antisense Oligonucleotides in the Study of Central Mechanisms of the Cardiovascular Regulation

  2000cites this paper
• Sequence design and practical implementation of antisense oligonucleotides in neuroendocrinology.

  2000cites this paper
• Antisense oligodeoxynucleotide and ribozyme design.

  2000cites this paper
• Antisense oligodeoxynucleotide effects on the hypothalamic-neurohypophysial system and the hypothalamic-pituitary-adrenal axis.

  2000cites this paper
• Antidiuretic Hormone: Synthesis and Release

  1999cites this paper
• How to Test Antisense Oligonucleotides in Animals

  1999cites this paper
• Brain as a Unique Antisense Environment

  1999cites this paper
• Introduction: antisense oligonucleotides: strategies and successes.

  1998cites this paper
• Rapid onset of antisense effects: evidence for a close link between gene expression and neuronal activity.

  1998cites this paper
• Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain.

  1998cites this paper
• Neuroendocrine and behavioral effects of antisense oligonucleotides.

  1997cites this paper
• Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: some prospects and problems.

  1997cites this paper
• Antisense oligonucleotides in neuroendocrinology: enthusiasm and frustration.

  1997cites this paper
• alpha1B adrenoceptors in rat paraventricular nucleus overlap with, but do not mediate, the induction of c-Fos expression by osmotic or restraint stress.

  1997cites this paper
• Antisense targeting in behavioural neuroendocrinology.

  1996cites this paper
• [Prospects of a more selective chemotherapy with antisense oligonucleotides].

  1996cites this paper
• Antisense oligonucleotides against transcription factor zif 268 transiently impair excitatory synaptic transmission in the hippocampus without affecting zif 268 immunoreactivity

  1996cites this paper
• Release of oxytocin within the supraoptic nucleus. Mechanisms, physiological significance and antisense targeting.

  1995cites this paper